Osteoporosis is a Serious and Common Complication of Corticosteroid Therapy; NOF Comments on New Treatment for Corticosteroid-Induced Osteoporosis
WASHINGTON, June 23 /PRNewswire/ -- A new treatment for corticosteroid- induced osteoporosis, Fosamax, offers hope for the millions of men and women suffering from arthritis, asthma, and many other diseases who need to take corticosteroids, but often develop osteoporosis as a result. Corticosteroids, powerful anti-inflammatory drugs such as prednisone and cortisone, are widely prescribed for many diseases. Doses as low as 7.5 mg per day greatly increase the risk of developing osteoporosis, a bone-thinning disease that leads to painful fractures, loss of height and independence, and can even lead to death.
``We are pleased the FDA has approved Fosamax for treatment of the bone loss caused by corticosteroids, the most common cause of secondary osteoporosis. Osteoporosis is a serious and common complication of prolonged corticosteroid therapy for men and women at any age,'' said C. Conrad Johnston, Jr., M.D., president of the National Osteoporosis Foundation. ``Bone loss increases with the dose and duration of corticosteroid treatment. Anyone about to go on long-term corticosteroids at higher doses, or anyone who has been on them, should have a bone density test. This new treatment provides doctors with a therapy to offer their patients who must take corticosteroids.''
Osteoporosis is a preventable and treatable disease affecting one in two women and one in eight men over age 50. Anyone at risk for osteoporosis, including people who must take corticosteroids, should ask their doctor about a bone density test, a painless test that can detect bone loss and diagnose osteoporosis before fractures occur. Some other osteoporosis risk factors include being female, being postmenopausal, having a family history of osteoporosis, a personal history of fractures, a thin or small build, and being Caucasian or Asian.
Osteoporosis is a major public health threat for more than 28 million Americans, 80 percent of whom are women. This disease causes nearly 1.5 million fractures annually and costs this country nearly $14 billion each year. Contrary to popular belief, osteoporosis is not an inevitable part of aging, but is a preventable disease for most people.
With more than 250,000 members, the National Osteoporosis Foundation is the only nonprofit, voluntary health organization dedicated to reducing the widespread prevalence of osteoporosis through programs of research, education, and advocacy.
The materials and information on this server are intended for educational and informational purposes only. The materials and information are not intended to replace the services of a trained health professional or to be a substitute for medical advice of physicians and/or other health care professionals. The International Still's Disease Foundation is not engaged in rendering medical or professional medical services. You should consult your physician on specific medical questions, particularly in matters requiring diagnosis or medical attention. The International Still's Disease Foundation makes no representations or warranties with respect to any treatment, action, application medication or preparation by any person following the information offered or provided within this website. Any information used from other websites was done so with permission from each site, with an exception to those of "public domain", whereas we believe any site without a cited reference was a "public domain site" and for our use. The International Still's Disease Foundation is a non-profit organization. This page was last updated on January 17, 2001
Copyrightę 1999-2001 International Still's Disease Foundation